Actively Recruiting
Ultrasound Imaging for the Assessment of Lower Urinary Tract Symptoms
Led by University of Wisconsin, Madison · Updated on 2025-12-22
80
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Wisconsin, Madison
Lead Sponsor
W
Wisconsin Partnership Program
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating a new ultrasound-based method to evaluate urinary flow and bladder pressure in men with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). This study aims to develop and validate this ultrasound urodynamics technique by comparing it to existing methods like MRI-urodynamics and multichannel urodynamics in both affected patients and healthy controls. The goal is to provide a more accessible and cost-effective way to assess urinary function. The study involves imaging procedures including dynamic MRI, 3D ultrasound, and multichannel urodynamics to measure voiding flow rates and bladder pressures. Men with BPH/LUTS and age-matched healthy men will undergo these evaluations during a single visit lasting up to 2.5 hours. Researchers will develop new analytic methods combining ultrasound and fluid dynamics modeling and will also use optical imaging to measure urine velocity during voiding. Participants will be assessed during one research visit involving MRI and ultrasound imaging along with clinical symptom scoring using the International Prostate Symptom Score (IPSS). The study will measure changes in bladder volume, urine velocity, pressure, and calculate standard indices related to bladder outlet obstruction and contractility. The total participation time is about 2.5 hours, and the study includes healthy volunteers as well as men diagnosed with BPH/LUTS. Safety is monitored by excluding participants with contraindications to MRI or recent urinary infections.
CONDITIONS
Brief Title
US Imaging for the Assessment of LUTS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients aged 18 to 80 years
- Diagnosed with BPH or lower urinary tract symptoms with or without obstruction
- Healthy male volunteers aged 18 to 80 years without symptoms of lower urinary tract symptoms
You will not qualify if you...
- Patients with contraindications to MRI and/or gadolinium-based contrast agents
- Diabetic subjects will not receive contrast
- History of overt neurologic disease other than diabetic neuropathy
- Urinary tract infection within the last 4 weeks
- Recent history of urinary retention within the last 4 weeks
- Currently taking medications known to affect the bladder (for healthy volunteers)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) to confirm eligibility and collect medical history
Duration - 1 day
Participants undergo imaging and urodynamic assessments including dynamic MRI, 3D ultrasound, and multichannel urodynamics (MCUD) to evaluate urinary tract function.
1 research visit (in-person)
Duration - Up to 5 years
Participants may be observed for changes in urinary tract symptoms and function without receiving treatment as this is an observational study.
Follow-up visits as needed depending on participant status
Trial Site Locations
Total: 1 location
1
University of Wisconsin
Madison, Wisconsin, United States, 53705
Actively Recruiting
Research Team
R
Radiology Studies
S
Suzanne Hanson, BS
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here